Dergiler / Pharmata / 2023 / Cilt: 3 Sayı: 4

The Relationship Between Euthyroid, Hyperthyroid, Hypothyroid, and Type 2 Diabetes

Sayfa
105–111
Yayın Tarihi
2023-10-09
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, most of the thyromimetics tested so far have been ineffective or toxic.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Diabetes mellitus (DM) and thyroid dysfunction, which have a significant incidence worldwide, are the most common endocrine system disorders that occur together in patients.
📊
Temel Bulgular & Veri:Our aim is to explain these 2 diseases with high incidence and the relationship between these 2 diseases.
💡
Sonuç & Katkı:However, most of the thyromimetics tested so far have been ineffective or toxic.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Diabetes · euthyroid · hyperthyroid

Özet

Diabetes mellitus (DM) and thyroid dysfunction, which have a significant incidence worldwide, are the most common endocrine system disorders that occur together in patients. Our aim is to explain these 2 diseases with high incidence and the relationship between these 2 diseases. Thyroid hormones (TH) are essential hormones that govern body metabolism. Thyroid hormone changes are thought to be effective on the pathogenesis of DM. Diabetes mellitus treatments can be beneficial, as TH changes may contribute to the pathogenesis of DM. However, more research needs to be done. This lack of information limits potential biomarkers and targets for diagnosis, prognosis, and the development of new DM treatments. The limitations of the use of natural THs have led to the development of synthetic hormones called thyromimetics. However, most of the thyromimetics tested so far have been ineffective or toxic.

🔖

Bu Makaleye Atıf Yap

KUTLU, Z., KAMACI, A. D. (2023). The Relationship Between Euthyroid, Hyperthyroid, Hypothyroid, and Type 2 Diabetes. Pharmata, Cilt: 3 Sayı: 4, 105–111. https://ajindex.com/articles/970815

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45-63
  2. Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377-390. [CrossRef] 3. Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014;42(12):698-702. [CrossRef] 4. Redondo MJ, Hagopian WA, Oram R, et al. The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia. 2020;63(10):2040-2048. [CrossRef] 5. Ozougwu O. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4(4):46-57
  3. Liu YC, Yeh CT, Lin KH. Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. Int J Mol Sci. 2019;20(20):4986.[CrossRef] 7. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008;29(7):898-938. [CrossRef] 8. Thvilum M, Brandt F, Brix TH, Hegedüs L. A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol. 2012;8(7):417-424. [CrossRef] 9. Pistollato F, Masias M, Agudo P, Giampieri F, Battino M. Effects of phytochemicals on thyroid function and their possible role in thyroid disease. Ann N Y Acad Sci. 2019;1443(1):3-19. [CrossRef] 10. Ragusa F, Fallahi P, Elia G, et al. Hashimotos’ thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367. [CrossRef] 11. MacFarland SP, Bauer AJ, Adzick NS, et al. Disease burden and outcome in children and young adults with concurrent graves disease and differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2018;103(8):2918-2925. [CrossRef] 12. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-382. [CrossRef] 13. Klieverik LP, Janssen SF, van Riel A, et al. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. Proc Natl Acad Sci U S A. 2009;106(14):5966-5971. [CrossRef] 14. López-Noriega L, Cobo-Vuilleumier N, Narbona-Pérez ÁJ, et al. Levothyroxine enhances glucose clearance and blunts the onset of experimental type 1 diabetes mellitus in mice. Br J Pharmacol. 2017;174(21):3795-3810. [CrossRef] 15. Celani MF, Bonati ME, Stucci N. Prevalence of abnormal thyrotropin concentrations